BasselFouadEl-RayesMD

PubMed

• A Case Series of Choroidal and Orbital Neuroendocrine Tumors: Metastasis: 2 Patients Treated with PRRT.
  Chris Bergstrom, Tony Zibo Zhuang, Bassel F El-Rayes, Walid L Shaib> ;Pancreas. 2024 Mar 14
• Deciphering cellular plasticity in pancreatic cancer for effective treatments.
  Md Hafiz Uddin, Dingqiang Zhang, Irfana Muqbil, Bassel F El-Rayes, Herbert Chen, Philip A Philip, Asfar S Azmi> ;Cancer Metastasis Reviews. 2024 Mar 1
• Advancing Inclusive Research (AIR) Site Alliance: Facilitating the inclusion of historically underrepresented people in oncology and ophthalmology clinical research.
  Vidal, G., Chalela, P., Curry, A., El-Rayes, B., Halmos, B., Herrera, A., Kapoor, K., Kaur, S., Mahadevan, D., Mesa, R., Ramirez, A., Sleckman, B., Wagner, A., Bhagat,...> ;Contemporary Clinical Trials. 2024 Feb 1
• 1 citations
  Advances in Immunotherapy for Hepatocellular Carcinoma (HCC).
  Fuat Bicer, Catrina Kure, Anil A Ozluk, Bassel F El-Rayes, Mehmet Akce> ;Current Oncology. 2023 Nov 7
• Implementation of the Web-Enabled Cancer & Aging Resilience Evaluation (WeCARE) in an outpatient oncology setting.
  Christian Harmon, Mackenzie Fowler, Smith Giri, Abigail Tucker, Mustafa Al-Obaidi, Gabrielle Rocque, Lisa Zubkoff, Laura Q Rogers, Tanya M Wildes, Mackenzi Pergolotti,...> ;Journal of Geriatric Oncology. 2023 Nov 1
• 1 citations
  Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer.
  Mehmet Akce, Batoul Farran, Jeffrey M Switchenko, Manali Rupji, Sandra Kang, Lana Khalil, Amanda Ruggieri-Joyce, Brian Olson, Walid L Shaib, Christina Wu, Olatunji B A...> ;Journal for Immunotherapy of Cancer. 2023 Oct 1
• Association of emotional support with quality of life, mental health, and survival in older adults with gastrointestinal malignancies-Results from the CARE registry.
  Daniel Clausing, Mackenzie E Fowler, Christian Harmon, Abigail Tucker, Darryl Outlaw, Mehmet Akce, Bassel El-Rayes, Smith Giri, Grant R Williams> ;Cancer Medicine. 2023 Sep 1
• Management of neuroendocrine tumor liver metastases.
  Rongzhi Wang, Addison Stewart, Clark Ingram, Andrea Gillis, J Bart Rose, Bassel El-Rayes, Asfar Azmi, Herbert Chen, Alex Harrelson> ;American Journal of Surgery. 2023 Nov 1
• 2 citations
  DNA-PK is activated by SIRT2 deacetylation to promote DNA double-strand break repair by non-homologous end joining.
  PamelaSara E Head, Priya Kapoor-Vazirani, Ganji P Nagaraju, Hui Zhang, Sandip K Rath, Nho C Luong, Ramona Haji-Seyed-Javadi, Fatmata Sesay, Shi-Ya Wang, Duc M Duong, W...> ;Nucleic Acids Research. 2023 Aug 25
• 1 citations
  Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions.
  Dhana Sekhar Reddy Bandi, Sujith Sarvesh, Batoul Farran, Ganji Purnachandra Nagaraju, Bassel F El-Rayes> ;Cytokine & Growth Factor Reviews. 2023 Jun 30
• Phase II randomised, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198).
  Walid L Shaib, Rupji Manali, Yuan Liu, Bassel El-Rayes, Patrick Loehrer, Bert O'Neil, Steven Cohen, Tina Khair, Erwin Robin, Timothy Huyck, Tanios Bekaii-Saab> ;European Journal of Cancer. 2023 Aug 1
• 4 citations
  Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell- and CXCR3-dependent manner.
  Michael Brandon Ware, Maggie Phillips, Christopher McQuinn, Mohammad Y Zaidi, Hannah M Knochelmann, Emily Greene, Brian Robinson, Cameron J Herting, Thomas A Mace, Zhe...> ;JCI Insight. 2023 Apr 24
• 3 citations
  Combinatorial targeting of immune checkpoints and epigenetic regulators for hepatocellular carcinoma therapy.
  Mehmet Akce, Bassel F El-Rayes, Narendra Wajapeyee> ;Oncogene. 2023 Mar 1
• Time to treatment initiation and its impact on real-world survival in metastatic colorectal cancer and pancreatic cancer.
  Olumide Gbolahan, Neda Hashemi-Sadraei, Suri Yash, Grant Williams, Rekha Ramachandran, Young-Il Kim, Ravikumar Paluri, Darryl Outlaw, Bassel El-Rayes, Lisle Nabell> ;Cancer Medicine. 2023 Feb 1
• Survival and Prognostic Factors in Patients With Pancreatic Colloid Carcinoma Compared With Pancreatic Ductal Adenocarcinoma.
  Lana Khalil, Zhonglu Huang, Katerina Zakka, Renjian Jiang, McKenna Penley, Olatunji B Alese, Walid L Shaib, Christina Wu, Madhusmita Behera, Michelle D Reid, Bassel F ...> ;Pancreas. 2023 Jan 1
• 2 citations
  Medullary carcinoma of the ampulla has distinct clinicopathologic characteristics including common association with microsatellite instability and PD-L1 expression.
  Yue Xue, Serdar Balci, Burcin Pehlivanoglu, Takashi Muraki, Bahar Memis, Burcu Saka, Grace Kim, Sudeshna Bandyopadhyay, Jessica Knight, Bassel El-Rayes, David Kooby, S...> ;Human Pathology. 2023 Jan 1
• 8 citations
  Understanding the molecular mechanisms that regulate pancreatic cancer stem cell formation, stemness and chemoresistance: A brief overview.
  Ganji Purnachandra Nagaraju, Batoul Farran, Tha Luong, Bassel F El-Rayes> ;Seminars in Cancer Biology. 2023 Jan 1
• 4 citations
  Fibroblast heterogeneity in pancreatic ductal adenocarcinoma: Perspectives in immunotherapy.
  Tha Luong, Yuvasri Golivi, Ganji Purnachandra Nagaraju, Bassel F El-Rayes> ;Cytokine & Growth Factor Reviews. 2022 Dec 1
• 3 citations
  Aberrant transcription factors in the cancers of the pancreas.
  Md Hafiz Uddin, Md Najeeb Al-Hallak, Philip A Philip, Herbert Chen, Bassel El-Rayes, Asfar S Azmi> ;Seminars in Cancer Biology. 2022 Nov 1
• 2 citations
  Biomarker analysis from a phase II multi-institutional study of nivolumab in patients with advanced refractory biliary tract cancer.
  Dae Won Kim, Vincent Chung, Olatunji B Alese, Bassel F El-Rayes, Daneng Li, Wungki Park, Richard D Kim, Kim, Y., Kovari, B.> ;European Journal of Cancer. 2022 Nov 1
• 7 citations
  Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma.
  Ravindranathan, S., Passang, T., Li, J., Wang, S., Dhamsania, R., Ware, M., Zaidi, M., Zhu, J., Cardenas, M., Liu, Y., Gumber, S., Robinson, B., Sen-Majumdar, A., Zhan...> ;Nature Communications. 2022 Oct 27
• 3 citations
  Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer.
  Amanda N Ruggieri, Mark Yarchoan, Subir Goyal, Yuan Liu, Elad Sharon, Helen X Chen, Brian M Olson, Chrystal M Paulos, Bassel F El-Rayes, Shishir K Maithel, Nilofer S A...> ;Clinical Cancer Research. 2022 Oct 3
• 1 citations
  Role of local therapy in the management of patients with metastatic anal squamous cell carcinoma: a National Cancer Database study.
  Rami P Atallah, Yining Zhang, Katerina Zakka, Renjian Jiang, Zhonglu Huang, Walid L Shaib, Maria Diab, Mehmet Akce, Christina Wu, Bassel F El-Rayes, Olatunji B Alese> ;Journal of Gastrointestinal Oncology. 2022 Oct 1
• 2 citations
  Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer.
  Lana Khalil, Xingyu Gao, Jeffrey M Switchenko, Olatunji B Alese, Mehmet Akce, Christina Wu, Maria Diab, Bassel F El-Rayes, Walid L Shaib> ;The Oncologist. 2022 Sep 2
• Correction: Refining colorectal cancer classification and clinical stratification through a single-cell atlas.
  Ateeq M Khaliq, Cihat Erdogan, Zeyneb Kurt, Sultan Sevgi Turgut, Miles W Grunvald, Tim Rand, Sonal Khare, Jefrey A Borgia, Dana M Hayden, Sam G Pappas, Henry R Govekar...> ;Genome Biology. 2022 Jul 13
• Join now to see all

Journal Articles

• "Heat Shock Protein 90 (HSP90) Promotes Epithelial to Mesenchymal Transition, Invasion, and Migration in Colorectal Cancer"  
  Nagaraju GP, Long TE, Park W, Landry JC,Taliaferro-Smith L, Farris AB, Diaz R, El-Rayes BF, Mol Carcinog, 1/27/2014
• "Cost Effectiveness Analysis of Pharmacokinetically-Guided 5-Fluorouracil in FOLFOX Chemotherapy for Metastatic Colorectal Cancer"  
  Goldstein DA, Chen Q, Ayer T, Howard DH, Lipscomb J, Harvey RD, El-Rayes BF, Flowers CR, Clin Colorectal Cancer, 1/21/2014
• "HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy"  
  Nagaraju GP, Alese OB, Landry J, Diaz R, El-Rayes BF, Oncotarget, 1/16/2014
• "Hepatoid Adenocarcinoma of the Lung: A Case Report and Review of the Literature"  
  Shaib W, Sharma R, Mosunjac M, Farris AB 3rd, El Rayes B, Journal of Gastrointestinal Cancer, 1/10/2014
• "Imaging and curcumin delivery in pancreatic cancer cell lines using PEGylated aplha-Gd2(MoO4)3 mesoporous particles"  
  Seeta Rama Raju G, Pavitra E, Purnachandra Nagaraju G, Ramesh K, El-Rayes BF, Yu JS, Dalton Trans, 1/1/2014
• "HER2 in resected gastric cancer: Is there prognostic value?"  
  Fisher SB, Fisher KE, Squires MH 3rd, Patel SH, Kooby DA, El-Rayes BF, Cardona K, Russell MC, Staley CA 3rd, Farris AB 3rd, Maithel SK, J Surg Oncol, 1/1/2014
• "Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point ...  
  Camacho JC, Kokabi N, Xing M, Prajapati HJ, El-Rayes B, Kim HS, J Vasc Interv Radiol, 1/1/2014
• "Chromodomain-Helicase-DNA-Binding Protein 7 (CHD7) expression predicts survival outcomes in patients with resected pancreatic cancer"  
  Colbert LE, Petrova AV, Fisher SB, Pantazides BG, Madden MZ, Hardy CW, Warren MD, Pan Y, Nagaraju GP, Liu, EA, Saka B, Hall WA, Shelton JW, Gandhi K, Pauly R, Kowalski..., Am J Clin Oncol, 1/1/2014
• "Clinicopathologic Features and Outcome of Young Adults with Stage IV Colorectal Cancer"  
  Hawk NN, Long T, Imam MH, Mathew BM, Kim S, Chen Z, Goodman M, Sullivan P, Brutcher E, Kauh J, Maithel SK, Adsay VN, Farris AB, El-Rayes BF, Am Journal of Clinical Onc, 1/1/2014
• "Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancer"  
  Bendell JC, Lenz HJ, Ryan T, El-Rayes BF, Marshall JL, Modiano MR, Hart LL, Kingsley CD, George TJ, Nakashima D, Berlin JD, Invest New Drugs, 1/1/2014
• "Locoregional therapies for metastatic colorectal carcinoma to the liver-An evidence-based review"  
  Xing M, Kooby DA, El-Rayes BF, Kokabi N, Camacho JC, Kim HS, J Surg Oncol, 1/1/2014
• "Value of intraoperative neck margin analysis during whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients"  
  Kooby DA, Lad NL, Squires MH 3rd, Maithel SK, Sarmiento JM, Staley CA, Adsay NV, El-Rayes BF, Weber SM, Winslow ER, Cho CS, Zavala KA, Bentrem DJ, Knab M, Ahmad SA, Ab..., Ann Surg, 1/1/2014
• "Targeted therapies in metastatic esophageal cancer: Advances over the past decade"  
  Mohamed A, El-Rayes B, Khuri, FR, Saba NF, Crit Rev Oncol Hematol, 1/1/2014
• "Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis"  
  Nagaraju GP, Dontula R, El-Rayes BF, Lakka SS, Carcinogenesis, 1/1/2014
• "Differential expression and prognostic value of ERCC1 and thymidylate synthase in resected gastric adenocarcinoma"  
  Squires MH 3rd, Fisher SB, Fisher KE, Patel SH, Kooby DA, El-Rayes BF, Staley CA 3rd, Farris AB 3rd, Maithel SK, Cancer, 1/29/2013
• "Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic Adenocarcinoma"  
  Colbert LE, Fisher SB, Hardy CW, Hall WA, Saka B, Shelton JW, Petrova AV, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay N..., Cancer, 1/29/2013
• "In Vitro and In Vivo Enhancement of Chemoradiation Using the Oral PARP Inhibitor ABT-888 in Colorectal Cancer Cells"  
  Shelton JW, Waxweiler TV, Landry J, Gao H, Xu Y, Wang L, El-Rayes B, Shu HK, Int J Radiat Oncol Biol Phys, 1/26/2013
• "Low CHD5 Expression Activates the DNA Damage Response and Predicts the Poor Outcome in Patients Undergoing Adjuvant Therapy for Resected Pancreatic Adenocarcinoma"  
  Hall WA, Petrova AV, Colbert LE, Hardy CW, Fisher SB, Saka B, Shelton JW, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA, Adsay NV, C..., Oncogene, 1/25/2013
• "Incidence and prognosis of gastroesophageal cancer in rural, urban and metropolitan areas of the United States"  
  Wang Z, Goodman M, Saba N, El-Rayes BF, Cancer, 1/20/2013
• "Carbohydrate antigen 19-9 is a Prognostic and Predictive Biomarker in Patients with Advanced Pancreatic Cancer who Receive Gemcitabine-containing Chemotherapy: A Pool...  
  Bauer TM, El-Rayes BF, Li X, Hammad N, Philip PA, Shields AF, Zalupski MM, Bekaii-Saab T, Cancer, 1/15/2013
• "An analysis of Human Equilibrative Nucleoside Transporter-1, Ribonucleoside Reductase Subunit M1, Ribonucleoside Reductase Subunit M2, and Excision Repair Cross-compl...  
  Fisher SB, Patel SH, Bagci P, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Maithel SK, Cancer, 1/15/2013
• "Excision Repair Cross-complementing Gene-1, Ribonucleotide Reductase Subunit M1, Ribonucleotide Reductase Subunit M2, and Human Equilibrative Nucleoside Transporter-1...  
  Fisher SB, Fisher KE, Patel SH, Lim MG, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Farris AB 3rd, Maithel SK, Cancer, 1/15/2013
• "Treatment Utilization and Surgical Outcome of Ampullary and Duodenal Adenocarcinoma"  
  Shaib WL, Sharma R, Brutcher E, Kim S, Maithel SK , Chen Z, Kooby DA, Kauh J, Landry J, El-Rayes BF, J Surg Oncol, 1/11/2013
• "Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1aplha and STAT-3"  
  Ganji PN, Park W, Wen J, Mahaseth H, Landry J, Farris AB, Willingham F, Sullivan PS, Proia DA, El-Hariry I, Taliaferro-Smith L, Diaz R, El-Rayes BF, Angiogenesis, 1/10/2013
• "Novel synthetic curcumin analogues EF31 and UBS109 are potent DNA hypomethylating agents in pancreatic cancer"  
  Nagaraju GP, Zhu S, Wen J, Farris AB, Adsay VN, Diaz R, Snyder JP, Mamoru S, El-Rayes BF, Cancer Letters, 1/7/2013
• Join now to see all

Books/Book Chapters

• Gastrointestinal Malignancies: New Innovative Diagnostics and Treatment 
  Cai Q, Xu H, El-Rayes B, Staley CAWorld Science Publishing Co. Pte. Ltd., Singapore2013
• Pancreatic Cancer-Clinical Management 
  Chapter: "Pancreatic Neuroendocrine Tumours: Emerging Management Paradigm" 
  Zafar SF, El-Rayes BEditors: S. Srivastava.2012
• Biliary Tract & Gallbladder Cancer: A Multidisciplinary Approach 
  Chapter: Systemic Therapy for Biliary Cancer. 
  El-Rayes B, Philip PEditors: C.R. Thomas & C. D. Fuller.New York, NY2009
• Pancreatic Cancer 
  Chapter: An Overview of Clinical Trials of Targeted Therapies in Pancreatic Cancer. 
  Page 565 - 575El-Rayes BSpringer, USA2008
• Encyclopaedia of Cancer 
  Chapter: Erlotinib. 
  B.F. El-Rayes, S. Gadgeel, S. Ali, P.A. Philip, F.H. SarkarSpringer, Berlin2008
• Encyclopaedia of Cancer 
  Chapter: Bryostatin-1. 
  B. El-Rayes2008
• Join now to see all

Abstracts/Posters

• "Anti-angiogenic effects of curcumin and its novel analogs EF-31 and UBS-109 in colorectal cancer."
  P. N. Ganji, S. Zhu, J. E. Ko, M. Shoji, B. F. El-Rayes, The Federation of American Society for Experimental Biology, 1/1/2013
• "Antiangiogenic activity of the HSP90 inhibitor ganetespib in pancreatic cancer models."
  P. N. Ganji, R. Diaz, B. F. El-Rayes, The Federation of American Society for Experimental Biology, 1/1/2013
• "Activity and safety of carboplatin and paclitaxel followed by capecitabine and radiation as adjuvant therapy for gastric cancer (GC)."
  B.F. El-Rayes, Gastrointestinal Cancers Symposium, 1/1/2008
• "A phase II study of isoflavone (Novasoy), gemcitabine, and erlotinib in locally advanced (LA) or metastatic pancreatic cancer."
  B.F. El-Rayes, Proceedings of ASCO, 1/1/2008
• "A phase II study of isoflavone (Novasoy), gemcitabine, and erlotinib in locally advanced (LA) or metastatic pancreatic cancer."
  B.F. El-Rayes, Gastrointestinal Cancers Symposium, 1/1/2008
• "A phase II study of Bevacizumab, docetaxel, and oxaliplatin in gastric and gastreosophageal junction (GEJ) cancer."
  B.F. El-Rayes, Gastrointestinal Cancers Symposium, 1/1/2008
• "A phase II study of Bevacizumab, docetaxel, and oxaliplatin in gastric and gastreosophageal junction (GEJ) cancer."
  B.F. El-Rayes, Proceedings of ASCO, 1/1/2008
• "A comparison of advanced pancreatic cancer patients treated on clinical trials with those from a SEER registry over an 18 year period."
  B.F. El-Rayes, Proceedings of ASCO, 1/1/2008
• "A comparison of advanced pancreatic cancer patients treated on clinical trials with those from a SEER registry over an 18 year period."
  B.F. El-Rayes, Gastrointestinal Cancers Symposium, 1/1/2008
• "Activity of safety of carboplatin and paclitaxel followed by capecitabine and radiation as adjuvant therapy for gastric cancer (GC)."
  B.F. El-Rayes, Proceedings of ASCO, 1/1/2007
• "The role of venography in the evaluation of malfunctioning central venous access ports (CVAPs)."
  B.F. El-Rayes, Proceedings of ASCO, 1/1/2006
• "A retrospective review of anal squamous cell carcinoma in HIV positive and HIV negative patients."
  B.F. El-Rayes, Proceedings of ASCO, 1/1/2006
• "A does attenuated schedule of irinotecan and capecitabine in combination with celecoxib in advanced colorectal cancer."
  B.F. El-Rayes, Proceedings of ASCO, 1/1/2006
• "A does attenuated schedule of irinotecan and capecitabine in combination with celecoxib in advanced colorectal cancer."
  B.F. El-Rayes, Gastrointestinal Cancers Symposium, 1/1/2006
• "CA 19-9 as a predictor of response and survival in patients with pancreatic cancer treated with gemcitabine and cisplatin based chemotherapy."
  B.F. El-Rayes, Proceedings of ASCO, 1/1/2005
• "A Phase II Trial of carboplatin, gemcitabine and capecitabine in patients with carcinoma of unknown primary site (CUP)."
  B.F. El-Rayes, Proceedings of ASCO, 1/1/2005
• "A Phase II Trial of Celecoxib, Irinotecan, and Capecitabine in Metastatic Colorectal Cancer."
  B.F. El-Rayes, Proceedings of ASCO, 1/1/2005
• "A Phase II Trial of Celecoxib, Irinotecan, and Capecitabine in Metastatic Colorectal Cancer."
  B.F. El-Rayes, Gastrointestinal Cancers Symposium, 1/1/2005
• "Targeting the Epidermal Growth Factor Receptor (EGFR) and Cyclooxygenase-2 (COX-2) pathways in Pancreatic Cancer."
  B.F. El-Rayes, GI Oncology Symposium, 1/1/2004
• "A Phase II study of Gemcitabine by fixed-dose rate infusion, cisplatin and celecoxib in metastatic pancreatic cancer."
  B.F. El-Rayes, Proceedings of ASCO, 1/1/2004
• "Phase II study of capecitabine, irinotecan, and celecoxib in advanced colorectal cancer."
  B.F. El-Rayes, Proceedings of ASCO, 1/1/2004
• "Phase I Study of flavopiridol and docetaxel."
  B.F. El-Rayes, Proceedings of ASCO, 1/1/2003
• "Phase I Study of the Protein Kinase C Modulator Bryostatain 1, and Gemcitabine."
  B.F. El-Rayes, Proceedings of ASCO, 1/1/2003
• "Protein Kinase C (PKC): A Target for Therapy in Pancreatic Cancer."
  B.F. El-Rayes, Proceedings of ASCO, 1/1/2003
• Join now to see all

Lectures

• Hematology/Oncology Grand Rounds, "Pancreatic Cancer: Current Status and Future Directions" 
  University of Cincinnati, Cincinnati, OH - 1/1/2014
• "Optimizing sequencing for colorectal cancer-What is best when?" 
  Sea Island, GA - 1/1/2014
• Hematology Oncology Grand Rounds: "Pancreatic Cancer Current Status and Future Direction" 
  University of Cincinnati, Cincinnati, OH - 1/1/2013
• "Gastrointestinal Malignancies" 
  Atlanta, GA - 1/1/2013
• "Translational GI Oncology Research at Emory" 
  Atlanta, GA - 1/1/2013
• "A Closer Look at Targeted Therapies in Metastatic Colorectal Cancer" 
  Gaylord Palms Resort, Orlando, FL - 1/1/2013
• "Gastrointestinal Cancers: Abstract Presentations and Questions" 
  Atlanta, GA - 1/1/2013
• "India-US Symposium on Translational Research in Oncology" 
  India - 1/1/2012
• "CTO Structure Supporting Winship GI Group" 
  Columbus, OH - 1/1/2012
• "Emory Symposium on Image-Guided Cancer Therapies" 
  Atlanta, GA - 1/1/2012
• "American Society of Clinical Oncology Leadership Skills Seminar" 
  ASCO Headquarters, Alexandria, VA - 1/1/2012
• "Personalized Medicine in Colorectal and Gastric Cancer" 
  Sea Island, GA - 1/1/2012
• "Systemic Treatment of Pancreatic Neuroendocrine Tumor" 
  Sea Island, GA - 1/1/2012
• "Gemcitabine Based Chemo for Pancreatic Cancer is Standard" 
  Sea Island, GA - 1/1/2012
• Session Chair, " NET Management Strategies: What's New & Relevant?" 
  Coronado Island Marriott Hotel, San Diego, CA - 1/1/2012
• "Keynote Speaker, Seventh Annual State of the Art Treatment of GASTROINTESTINAL CANCERS" 
  The Somerset Inn, Troy, MI - 1/1/2012
• "Colon and Rectal Cancer Updates after ASCO 2011" 
  Konya, Turkey - 1/1/2011
• Medicine Grand Rounds: "Management of Colorectal Cancer" 
  Emory University School of Medicine - 1/1/2011
• GI Grand Rounds: "Pancreatic Cancer" 
  Emory University School of Medicine - 1/1/2011
• "The Screening, Prevention & Treatment of Colorectal Cancer" 
  Decatur, GA - 1/1/2011
• Medical Grand Rounds: "Recent Advances in the Management of Pancreatic Cancer" 
  Roswell Park Cancer Institute, Buffalo, NY - 1/1/2011
• Medicine Grand Rounds: "Recent Development in Colorectal Cancer" 
  Emory University School of Medicine, Atlanta, GA - 1/1/2011
• "Preoperative vs. Adjunct Therapy for GI Cancers" 
  Sea Island, GA - 1/1/2011
• "Ganetespib in Rectal Cancer" 
  New York, NY - 1/1/2011
• "Metastatic Colon Cancer: More Drugs at Induction are Better?" 
  Sea Island, GA - 1/1/2010
• Join now to see all

Other

• "Gastrointestinal Malignancies: New Innovative Diagnostics and Treatment, World Science Publishing Co. Pte. Ltd., Singapore" 
  Cai Q, Xu H, El-Rayes B, Kooby D (editors)
  1/1/2013
• Interview: "Breast Cancer in patients with HIV" 
  Bassel F. El-Rayes, MD, HIV Plus
  1/1/2003